ABTAbbott Laboratories

ABT Stock Price, Valuation & Chart | Abbott Laboratories

Compare

$110.49+1.56 (+1.43%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Medical - Devices ABT intrinsic value ABT calculated fair value vs price

Overview Financials Dividends Ratios

ABT Historical price chart

ABT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization191.19B

PE Ratio21.21

EPS5.21

Trading Volume8.37M

Today's High/Low112.2/109.0

Dividend Yield2.24

52 Week High/Low137.49/81.97

Shares Outstanding1.73B

ABT Financial Statement

ABT Analyst ratings

ABT Analysis & performance metrics

ABT Company profile

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established…

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine…

ABT Management team

Name

Position

Daniel Gesua Sive Salvadori

Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

Sabina EwingCTO

Senior Vice President of Business & Technology Services and Chief Information Officer

Elizabeth Cushman

Executive Vice President, General Counsel & Secretary

Mary K. Moreland

Executive Vice President of Human Resources

Michael Comilla

Vice President of Investor Relations.

Robert B. FordCEO

Chairman of the Board, President & Chief Executive Officer

Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

Philip P. BoudreauCFO

Chief Financial Officer & Executive Vice President of Finance

Name

Position

Daniel Gesua Sive Salvadori

Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

Sabina EwingCTO

Senior Vice President of Business & Technology Services and Chief Information Officer

Elizabeth Cushman

Executive Vice President, General Counsel & Secretary

Mary K. Moreland

Executive Vice President of Human Resources

Michael Comilla

Vice President of Investor Relations.

Robert B. FordCEO

Chairman of the Board, President & Chief Executive Officer

Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

Philip P. BoudreauCFO

Chief Financial Officer & Executive Vice President of Finance

Management Team

Daniel Gesua Sive Salvadori

Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

Sabina EwingCTO

Senior Vice President of Business & Technology Services and Chief Information Officer

Elizabeth Cushman

Executive Vice President, General Counsel & Secretary

Mary K. Moreland

Executive Vice President of Human Resources

Michael Comilla

Vice President of Investor Relations.

Robert B. FordCEO

Chairman of the Board, President & Chief Executive Officer

Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

Philip P. BoudreauCFO

Chief Financial Officer & Executive Vice President of Finance

Management

Daniel Gesua Sive Salvadori

Executive Vice President and Group President of Established Pharmaceuticals & Nutritional Products

Sabina EwingCTO

Senior Vice President of Business & Technology Services and Chief Information Officer

Elizabeth Cushman

Executive Vice President, General Counsel & Secretary

Mary K. Moreland

Executive Vice President of Human Resources

Michael Comilla

Vice President of Investor Relations.

Robert B. FordCEO

Chairman of the Board, President & Chief Executive Officer

Melissa Brotz

Senior Vice President of Global Marketing & External Affairs

Philip P. BoudreauCFO

Chief Financial Officer & Executive Vice President of Finance

Total 8 executives

ABT Frequently asked questions

What is Abbott Laboratories (ABT) Stock Price?

Current stock price of Abbott Laboratories (ABT) stock is $110.49. The stock price is +1.43% higher in the session. The intraday range can be seen from this page. Volume of Abbott Laboratories (ABT) stock is 8.37M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Abbott Laboratories (ABT) stock price going up or down today?

The stock price of Abbott Laboratories (ABT) can change with earnings, company news, and overall market sentiment. Abbott Laboratories operates in the Healthcare / Medical - Devices market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Abbott Laboratories stock expensive at its current price?

Whether Abbott Laboratories looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ABT on this page is 21.21. EPS on this page is 5.21. Compare those figures with peers and growth expectations before deciding if the current Abbott Laboratories price is justified.

How has the stock price of Abbott Laboratories (ABT) performed historically?

Historical performance for Abbott Laboratories (ABT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ABT reacted to past earnings and market events.

Should I buy Abbott Laboratories (ABT) stock, at this price?

Buying Abbott Laboratories (ABT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.